UBS Group’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.7M | Buy |
1,693,292
+356,421
| +27% | +$2.04M | ﹤0.01% | 2434 |
|
|
2025
Q1 | $10.9M | Buy |
1,336,871
+256,840
| +24% | +$2.1M | ﹤0.01% | 2274 |
|
|
2024
Q4 | $10.2M | Buy |
1,080,031
+516,059
| +92% | +$4.86M | ﹤0.01% | 2320 |
|
|
2024
Q3 | $6.02M | Buy |
563,972
+77,205
| +16% | +$825K | ﹤0.01% | 2107 |
|
|
2024
Q2 | $4.83M | Sell |
486,767
-411,129
| -46% | -$4.08M | ﹤0.01% | 2158 |
|
|
2024
Q1 | $10.6M | Buy |
897,896
+73,188
| +9% | +$862K | ﹤0.01% | 1573 |
|
|
2023
Q4 | $11.7M | Buy |
824,708
+303,038
| +58% | +$4.3M | ﹤0.01% | 1373 |
|
|
2023
Q3 | $6.34M | Buy |
521,670
+121,102
| +30% | +$1.47M | ﹤0.01% | 1680 |
|
|
2023
Q2 | $5.03M | Buy |
400,568
+130,321
| +48% | +$1.64M | ﹤0.01% | 1903 |
|
|
2023
Q1 | $3M | Sell |
270,247
-306,104
| -53% | -$3.39M | ﹤0.01% | 2241 |
|
|
2022
Q4 | $7.04M | Buy |
576,351
+392,760
| +214% | +$4.8M | ﹤0.01% | 1579 |
|
|
2022
Q3 | $1.92M | Sell |
183,591
-96,739
| -35% | -$1.01M | ﹤0.01% | 2383 |
|
|
2022
Q2 | $3.01M | Sell |
280,330
-232,112
| -45% | -$2.49M | ﹤0.01% | 2113 |
|
|
2022
Q1 | $4.85M | Buy |
512,442
+36,572
| +8% | +$346K | ﹤0.01% | 1954 |
|
|
2021
Q4 | $5.5M | Buy |
475,870
+148,024
| +45% | +$1.71M | ﹤0.01% | 2013 |
|
|
2021
Q3 | $3.13M | Buy |
327,846
+184,656
| +129% | +$1.76M | ﹤0.01% | 2411 |
|
|
2021
Q2 | $1.38M | Sell |
143,190
-185,310
| -56% | -$1.79M | ﹤0.01% | 3013 |
|
|
2021
Q1 | $3.25M | Buy |
328,500
+61,602
| +23% | +$609K | ﹤0.01% | 2325 |
|
|
2020
Q4 | $6.16M | Buy |
266,898
+89,438
| +50% | +$2.06M | ﹤0.01% | 1692 |
|
|
2020
Q3 | $2.51M | Sell |
177,460
-5,331
| -3% | -$75.3K | ﹤0.01% | 2241 |
|
|
2020
Q2 | $2.76M | Buy |
182,791
+8,327
| +5% | +$126K | ﹤0.01% | 2036 |
|
|
2020
Q1 | $1.61M | Sell |
174,464
-124,974
| -42% | -$1.15M | ﹤0.01% | 2317 |
|
|
2019
Q4 | $2.92M | Sell |
299,438
-556,404
| -65% | -$5.42M | ﹤0.01% | 2458 |
|
|
2019
Q3 | $6.86M | Buy |
855,842
+561,151
| +190% | +$4.5M | ﹤0.01% | 1623 |
|
|
2019
Q2 | $3.68M | Buy |
294,691
+137,703
| +88% | +$1.72M | ﹤0.01% | 2036 |
|
|
2019
Q1 | $2.14M | Sell |
156,988
-696,041
| -82% | -$9.47M | ﹤0.01% | 2377 |
|
|
2018
Q4 | $8.17M | Buy |
853,029
+579,214
| +212% | +$5.55M | ﹤0.01% | 1365 |
|
|
2018
Q3 | $3.31M | Buy |
273,815
+344
| +0.1% | +$4.16K | ﹤0.01% | 2205 |
|
|
2018
Q2 | $4.27M | Sell |
273,471
-276,268
| -50% | -$4.32M | ﹤0.01% | 1974 |
|
|
2018
Q1 | $8.27M | Buy |
549,739
+316,537
| +136% | +$4.76M | ﹤0.01% | 1493 |
|
|
2017
Q4 | $3.36M | Sell |
233,202
-70,421
| -23% | -$1.01M | ﹤0.01% | 2147 |
|
|
2017
Q3 | $4.58M | Buy |
303,623
+181,771
| +149% | +$2.74M | ﹤0.01% | 1805 |
|
|
2017
Q2 | $1.23M | Buy |
121,852
+17,461
| +17% | +$176K | ﹤0.01% | 2768 |
|
|
2017
Q1 | $744K | Sell |
104,391
-157,867
| -60% | -$1.13M | ﹤0.01% | 3029 |
|
|
2016
Q4 | $1.3M | Buy |
262,258
+118,545
| +82% | +$589K | ﹤0.01% | 2623 |
|
|
2016
Q3 | $1.06M | Sell |
143,713
-32,867
| -19% | -$243K | ﹤0.01% | 2697 |
|
|
2016
Q2 | $965K | Buy |
176,580
+88,298
| +100% | +$483K | ﹤0.01% | 2723 |
|
|
2016
Q1 | $746K | Buy |
88,282
+24,655
| +39% | +$208K | ﹤0.01% | 2857 |
|
|
2015
Q4 | $617K | Buy |
63,627
+19,486
| +44% | +$189K | ﹤0.01% | 3011 |
|
|
2015
Q3 | $617K | Buy |
44,141
+13,597
| +45% | +$190K | ﹤0.01% | 2951 |
|
|
2015
Q2 | $432K | Buy |
30,544
+13,144
| +76% | +$186K | ﹤0.01% | 3365 |
|
|
2015
Q1 | $189K | Buy |
17,400
+1,900
| +12% | +$20.6K | ﹤0.01% | 3830 |
|
|
2014
Q4 | $129K | Buy |
+15,500
| New | +$129K | ﹤0.01% | 4059 |
|